Bifogade filer
PDF
Kurs
+3,18%
Likviditet
1,88 MEUR
Kalender
| Tid* | ||
| 2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-17 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-04-25 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-04-08 | N/A | Årsstämma |
| 2025-02-14 | 08:00 | Bokslutskommuniké 2024 |
| 2024-10-25 | - | Kvartalsrapport 2024-Q3 |
| 2024-10-08 | - | X-dag halvårsutdelning TTALO 0.15 |
| 2024-07-17 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-26 | - | Kvartalsrapport 2024-Q1 |
| 2024-03-27 | - | X-dag halvårsutdelning TTALO 0.15 |
| 2024-03-26 | - | Årsstämma |
| 2024-02-14 | - | Bokslutskommuniké 2023 |
| 2023-10-27 | - | Kvartalsrapport 2023-Q3 |
| 2023-09-29 | - | X-dag halvårsutdelning TTALO 0.14 |
| 2023-07-18 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-24 | - | X-dag halvårsutdelning TTALO 0.14 |
| 2023-03-23 | - | Årsstämma |
| 2023-02-10 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-10-07 | - | X-dag halvårsutdelning TTALO 0.14 |
| 2022-07-19 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-08 | - | X-dag halvårsutdelning TTALO 0.14 |
| 2022-04-07 | - | Årsstämma |
| 2022-02-10 | - | Bokslutskommuniké 2021 |
| 2021-10-29 | - | X-dag halvårsutdelning TTALO 0.13 |
| 2021-10-28 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-12 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-29 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-26 | - | X-dag halvårsutdelning TTALO 0.13 |
| 2021-03-25 | - | Årsstämma |
| 2021-02-11 | - | Bokslutskommuniké 2020 |
| 2020-10-29 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-06 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-01 | - | X-dag ordinarie utdelning TTALO 0.13 EUR |
| 2020-05-28 | - | Årsstämma |
| 2020-05-06 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-03 | - | X-dag halvårsutdelning TTALO 0.13 |
| 2020-02-13 | - | Bokslutskommuniké 2019 |
| 2019-10-31 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-08 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-09 | - | Kvartalsrapport 2019-Q1 |
| 2019-04-05 | - | X-dag ordinarie utdelning TTALO 0.20 EUR |
| 2019-04-04 | - | Årsstämma |
| 2019-02-14 | - | Bokslutskommuniké 2018 |
| 2018-11-14 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-17 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-16 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-13 | - | X-dag ordinarie utdelning TTALO 0.06 EUR |
| 2018-04-12 | - | Årsstämma |
| 2018-02-28 | - | Bokslutskommuniké 2017 |
Beskrivning
| Land | Finland |
|---|---|
| Lista | Mid Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
Terveystalo Plc stock exchange release 25 October 2024 at 9.05 a.m. EEST
Petteri Lankinen, born in 1981, Doctor of Medical Science, eMBA, has been appointed as Terveystalo's Chief Medical Officer and member of the Executive Team. He will take up his position on 25 January 2025 at the latest. Dr. Lankinen is a licensed specialist and an adjunct professor in orthopaedics and traumatology. He will report directly to CEO Ville Iho. Dr. Lankinen transitions to this new role from his position as Chief Medical Officer and Senior Partner at Nordic Healthcare Group, a consultancy firm, where he has been since 2023. His previous experience includes serving as the Managing Director of Specialized Health Care and Hospital Services in the Wellbeing Services County of Satakunta, as well as holding the role of Chief Medical Officer at Satakunta Hospital District and Turku University Hospital, among others.
-I warmly welcome Petteri to Terveystalo and our Executive Team. Petteri brings expertise in specialized medical care and leadership experience in the orthopaedic specialty, as well as insight into the partnership needs of public healthcare. His deep expertise in measuring the effectiveness of care supports the implementation of our strategy, according to Ville Iho, CEO of Terveystalo.
-Terveystalo is recognized for its exceptional medical quality and its pivotal role in creating efficient and effective healthcare systems within society. It is truly inspiring to collaborate on developing Terveystalo's integrated care strategy alongside its esteemed professionals, says Petteri Lankinen.
Attachment: CV, Petteri Lankinen
Terveystalo Communications
Distribution:
Nasdaq Helsinki Oy
Principal media
www.terveystalo.com